Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone PCIA administration modes for rebound pain after femoral nerve block in knee arthroplasty
ChiCTR2200062497Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of oxycodone in acute postoperative pain (3 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoint: Difference in pain scores before and after nerve block disappearance. Planned start Jun 2022; status: not yet recruiting.
02
Drugs
oxycodone
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on ChiCTR2200062497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062497.